Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1998 1
2000 2
2009 1
2012 8
2013 4
2014 22
2015 191
2016 4513
2017 12064
2018 12693
2019 13528
2020 15596
2021 17408
2022 17814
2023 18460
2024 8801
2025 4

Text availability

Article attribute

Article type

Publication date

Search Results

106,639 results

Results by year

Filters applied: . Clear all
Page 1
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease.
Khan S, Barve KH, Kumar MS. Khan S, et al. Curr Neuropharmacol. 2020;18(11):1106-1125. doi: 10.2174/1570159X18666200528142429. Curr Neuropharmacol. 2020. PMID: 32484110 Free PMC article. Review.
BACKGROUND: The only conclusive way to diagnose Alzheimer's is to carry out brain autopsy of the patient's brain tissue and ascertain whether the subject had Alzheimer's or any other form of dementia. ...Thus, a standard drug regimen ensues in every …
BACKGROUND: The only conclusive way to diagnose Alzheimer's is to carry out brain autopsy of the patient's brain tissue and as …
2023 Alzheimer's disease facts and figures.
[No authors listed] [No authors listed] Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14. Alzheimers Dement. 2023. PMID: 36918389
Official death certificates recorded 121,499 deaths from AD in 2019, and Alzheimer's disease was officially listed as the sixth-leading cause of death in the United States. ...The Special Report examines whether there will be sufficient numbers of physician s …
Official death certificates recorded 121,499 deaths from AD in 2019, and Alzheimer's disease was officially listed as t …
Alzheimer's disease.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Scheltens P, et al. Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2. Lancet. 2021. PMID: 33667416 Free PMC article. Review.
The risk of Alzheimer's disease is 60-80% dependent on heritable factors, with more than 40 Alzheimer's disease-associated genetic risk loci already identified, of which the APOE alleles have the strongest association with the disease …
The risk of Alzheimer's disease is 60-80% dependent on heritable factors, with more than 40 Alzheimer's …
Alzheimer's disease.
Soria Lopez JA, González HM, Léger GC. Soria Lopez JA, et al. Handb Clin Neurol. 2019;167:231-255. doi: 10.1016/B978-0-12-804766-8.00013-3. Handb Clin Neurol. 2019. PMID: 31753135 Review.
Alzheimer's disease (AD) dementia refers to a particular onset and course of cognitive and functional decline associated with age together with a particular neuropathology. ...Alzheimer's disease is now the most common form of neurodegene …
Alzheimer's disease (AD) dementia refers to a particular onset and course of cognitive and functional decline associate …
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors. Jack CR Jr, et al. Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. Alzheimers Dement. 2018. PMID: 29653606 Free PMC article. Review.
In 2011, the National Institute on Aging and Alzheimer's Association created separate diagnostic recommendations for the preclinical, mild cognitive impairment, and dementia stages of Alzheimer's disease. ...In the National Institute on Aging an …
In 2011, the National Institute on Aging and Alzheimer's Association created separate diagnostic recommendations for the precl …
The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention.
Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT. Zhang XX, et al. J Prev Alzheimers Dis. 2021;8(3):313-321. doi: 10.14283/jpad.2021.15. J Prev Alzheimers Dis. 2021. PMID: 34101789 Review.
Mild Alzheimer's disease is the leading cause of dementia, accounting for 50-70% of cases. Alzheimer's disease is an irreversible neurodegenerative disease, which affects daily life activities and social functioning. ...
Mild Alzheimer's disease is the leading cause of dementia, accounting for 50-70% of cases. Alzheimer's …
The Gut Microbiota and Alzheimer's Disease.
Jiang C, Li G, Huang P, Liu Z, Zhao B. Jiang C, et al. J Alzheimers Dis. 2017;58(1):1-15. doi: 10.3233/JAD-161141. J Alzheimers Dis. 2017. PMID: 28372330 Review.
The gut microbiota comprises a complex community of microorganism species that resides in our gastrointestinal ecosystem and whose alterations influence not only various gut disorders but also central nervous system disorders such as Alzheimer's disease (AD). …
The gut microbiota comprises a complex community of microorganism species that resides in our gastrointestinal ecosystem and whose alteratio …
Is Alzheimer's Disease Risk Modifiable?
Serrano-Pozo A, Growdon JH. Serrano-Pozo A, et al. J Alzheimers Dis. 2019;67(3):795-819. doi: 10.3233/JAD181028. J Alzheimers Dis. 2019. PMID: 30776012 Free PMC article. Review.
Population-based clinic-pathological studies have established that the most common pathological substrate of dementia in community-dwelling elderly people is mixed, especially Alzheimer's disease (AD) and cerebrovascular ischemic disease (CVID), rather …
Population-based clinic-pathological studies have established that the most common pathological substrate of dementia in community-dwelling …
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options.
Cummings JL, Tong G, Ballard C. Cummings JL, et al. J Alzheimers Dis. 2019;67(3):779-794. doi: 10.3233/JAD-180766. J Alzheimers Dis. 2019. PMID: 30689575 Free PMC article. Review.
Although Alzheimer's disease (AD) is the world's leading cause of dementia and the population of patients with AD continues to grow, no new therapies have been approved in more than a decade. Many clinical trials of single-agent therapies have failed to affec …
Although Alzheimer's disease (AD) is the world's leading cause of dementia and the population of patients with AD conti …
Mouse Models of Alzheimer's Disease.
Esquerda-Canals G, Montoliu-Gaya L, Güell-Bosch J, Villegas S. Esquerda-Canals G, et al. J Alzheimers Dis. 2017;57(4):1171-1183. doi: 10.3233/JAD-170045. J Alzheimers Dis. 2017. PMID: 28304309 Review.
Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than 40 million people worldwide and it is predicted to exponentially increase in the coming decades. Because no curative treatment exists, research on the pathophysiology of …
Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than 40 million people worldwide an …
106,639 results
You have reached the last available page of results. Please see the User Guide for more information.